Skip to main content
NANOVIRICIDES, INC. logo

NANOVIRICIDES, INC. — Investor Relations & Filings

Ticker · NNVC ISIN · US6300873022 LEI · 5493003CK9Y2H0OORR73 US Professional, scientific and technical activities
Open in API
Filings indexed 536 across all filing types
Latest filing 2013-02-04 Regulatory Filings
Country US United States of America
Listing US NNVC

About NANOVIRICIDES, INC.

https://www.nanoviricides.com/

NanoViricides, Inc. is a clinical-stage biopharmaceutical company developing a novel class of nanomedicine-based antiviral therapeutics. The company's proprietary platform technology creates "nanoviricides," which are designed to be broad-spectrum drugs that viruses cannot easily evade through mutation. The technology is biomimetic, mimicking the host cell receptors that viruses use for entry. A nanoviricide is engineered to attract and bind to a virus particle, subsequently trapping and dismantling it to neutralize the threat. The company's development pipeline targets a wide range of viral infections, including respiratory viruses such as RSV, influenza, and coronaviruses, as well as herpesviruses (shingles, cold sores), HIV, and hemorrhagic fever viruses.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2013
Regulatory Filings
2013-02-04 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving a $6 million offering of convertible debentures, detailing terms of the debt, interest, conversion rights, and registration efforts. It also discusses the unregistered sale of equity securities under exemptions. This is a financing update about capital raising and related securities issuance. The document is not a full financial report, earnings release, or management discussion, but rather an announcement of a financing transaction. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a confident classification.
2013-02-01 English
FORM 4
Director's Dealing
2013-02-01 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content details an amendment and consummation of a Securities Purchase Agreement involving Series C Convertible Preferred Stock, including terms of conversion, purchase price, and related agreements. It also references prior filings and includes exhibits related to the financing agreement. The document is focused on a material definitive agreement and financing activity rather than a full annual or quarterly report, audit, or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is over 10,000 characters and contains substantive details about the financing transaction, not just an announcement or summary, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2012-12-27 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a securities offering by NanoViricides, Inc. It details the terms of the offering of Series C Convertible Preferred Stock and Common Stock, including pricing, conversion terms, use of proceeds, risk factors, and plan of distribution. The document is a registration and offering document for capital raising purposes, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual offering document. Therefore, it fits the category of Capital/Financing Update filings, which cover company fundraising and financing activities.
2012-12-27 English
Regulatory Filings 2012
Regulatory Filings
2012-12-24 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.